Literature DB >> 9755249

Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.

A Piperno1, A Vergani, I Malosio, L Parma, L Fossati, A Ricci, G Bovo, G Boari, G Mancia.   

Abstract

Mild to moderate hepatic iron overload is frequent in patients with chronic viral hepatitis (CH). We evaluated the role of hemochromatosis (HFE) gene mutations and other acquired factors in the development of iron overload in these patients. We studied 110 patients with chronic B or C viral hepatitis (31 women, 79 men), including 20 with cirrhosis, and 139 controls. Hepatic iron was evaluated by semiquantitative analysis in all the patients, and hepatic iron concentration (HIC) was determined in 97 of them (26 women, 71 men). C282Y and H63D mutations were sought in all the subjects by a polymerase chain reaction-restriction assay. The frequency of HFE genotypes and alleles did not differ in patients and controls. No relation was detected between hepatic iron stores and HFE gene mutations in women. In men, all C282Y heterozygotes had iron overload, and the H63D mutation was significantly more frequent in patients with more marked hepatic siderosis than in those with mild or no siderosis (P = .0039) and in controls (P = .0008). Heavy alcohol intake and hepatic cirrhosis were also associated with increased hepatic iron stores in the men. In the 71 men in whom HIC was measured, multiple regression analysis showed that this variable was related independently only to alcohol intake and HFE gene mutations. We suggest that in patients with CH, iron accumulates in the liver as the result of an interplay between genetic and acquired factors, and that increased liver iron stores may influence progression toward liver fibrosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9755249     DOI: 10.1002/hep.510280427

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  18 in total

1.  Iron metabolic disorder in chronic hepatitis C: insights from recent evidence.

Authors:  Keisuke Hino; Sohji Nishina; Yuichi Hara
Journal:  Clin J Gastroenterol       Date:  2012-07-31

2.  Liver iron is predictive of death in alcoholic cirrhosis: a multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: a prospective follow up study.

Authors:  N Ganne-Carrié; C Christidis; C Chastang; M Ziol; F Chapel; F Imbert-Bismut; J C Trinchet; C Guettier; M Beaugrand
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

3.  The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C.

Authors:  D Thorburn; G Curry; R Spooner; E Spence; K Oien; D Halls; R Fox; E A B McCruden; R N M MacSween; P R Mills
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

4.  The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection.

Authors:  S Barrett; J Goh; B Coughlan; E Ryan; S Stewart; A Cockram; J C O'Keane; J Crowe
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

Review 5.  The role of iron in the pathophysiology and treatment of chronic hepatitis C.

Authors:  Leslie Price; Kris V Kowdley
Journal:  Can J Gastroenterol       Date:  2009-12       Impact factor: 3.522

Review 6.  Manipulation of iron to determine survival: competition between host and pathogen.

Authors:  Nihay Laham; Rachel Ehrlich
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

7.  Lack of association between HFE gene mutations and hepatocellular carcinoma in patients with cirrhosis.

Authors:  V Boige; L Castéra; N de Roux; N Ganne-Carrié; B Ducot; G Pelletier; M Beaugrand; C Buffet
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

8.  The effect of iron depletion on chronic hepatitis C virus infection.

Authors:  Massimo Franchini; Giovanni Targher; Franco Capra; Martina Montagnana; Giuseppe Lippi
Journal:  Hepatol Int       Date:  2008-05-08       Impact factor: 6.047

9.  Hemochromatosis gene mutations: prevalence and effects on pegylated-interferon and ribavirin therapy response in chronic hepatitis C in sardinia.

Authors:  Margherita Sini; Orazio Sorbello; Alberto Civolani; Luigi Demelia
Journal:  J Clin Exp Hepatol       Date:  2012-09-21

Review 10.  HFE gene in primary and secondary hepatic iron overload.

Authors:  Giada Sebastiani; Ann-P Walker
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.